January 13 - 17, 2014
Renaissance Hotel and Palm Springs Convention Center Palm Springs, California

A Community Dedicated to the
Evolving Field and Future of Biotherapeutics
2014 Archived Content



Tuesday, January 14 | 5:00-8:00 pm

This short course will aim to outline the considerations and direction taken when evaluating and understanding Extractables and Leachables present in either Single-Use Systems or Final Packaging. The course will be begin with outlining key fundamentals of material chemistry and typical leachable sources, while also highlighting properties that govern migration of these compounds. Further incorporation of industry-recognized "best practices" with these concepts will introduce evaluation strategies and explain the thought process in designing appropriate analytical studies to assess these systems. Throughout the course, strategies to overcome typical obstacles encountered in such E&L programs will be illustrated. Finally, resources associated with establishing suitable testing criteria and safety assessments will be presented.

The topics to be covered:

  • Which phenomena are described by the term “protein aggregation”?
  • How do protein aggregates form, and what factors influence their formation?
  • What are the consequences of aggregate formation?
  • Can aggregation be predicted?
  • What are the key analytical challenges and tools for characterization of protein aggregates?



Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Head, Industrial and Physical Pharmacy, Purdue University

Daniel Some, Ph.D., Principal Scientist, Wyatt Technology

Speaker Biographies


Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Head, Industrial and Physical Pharmacy, Purdue University

Elizabeth M. Topp is Dane O. Kildsig Chair and Head of the Department of Industrial and Physical Pharmacy at Purdue University in West Lafayette, Indiana.  She received a bachelor’s degree in chemical engineering from the University of Delaware in 1979 (B.Ch.E.), a master’s in chemical and biochemical engineering from the University of Pennsylvania in1984 (M.E.) and a Ph.D. in pharmaceutics from the University of Michigan in 1986. Dr. Topp’s research addresses the chemical and physical stability of protein drugs, with particular emphasis on the solid state. She currently serves as acting chair of the Advisory Committee on the Pharmaceutical Sciences and Clinical Pharmacology for the U.S. Food and Drug Administration and is a Fellow of the American Association of Pharmaceutical Scientists.

Daniel Some, Ph.D., Principal Scientist, Wyatt Technology

Daniel Some is Principal Scientist and Director of Marketing at Wyatt Technology Corp. Previously he was product manager for the Calypso system, responsible for developing the hardware and software of CG-MALS. He has authored a review article, a book chapter and multiple application notes on CG-MALS as well as several patent applications. Prior to joining Wyatt Technology, Dr. Some spent over a decade in the semiconductor and defense industries.

«Back to Short Courses 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

PTK Event APP 
New this year!
The PepTalk App will allow attendees to browse the agenda, create custom schedules, navigate the exhibit hall and explore poster presentations.

2014 Brochure Cover 

Right Arrow Download the Brochure 

Right Arrow Event at-a Glance 

      Premier Sponsors: 

EMD Millipore 

 Novozymes (white) 

PerkinElmer NEW 2009 

 Protein Simple  


Right Arrow View All Sponsors 

Right Arrow View Media Partners 

Add to Outlook Add to Outlook 

Training Seminars 

Mon-Tues, January 13-14 

Biologics Formulation and Delivery  


Buzz Sessions
BuzZ Sessions are facilitated, small-group discussions. Interactive participation leads to problem-solving solutions and future collaborations around focused topics.
Click here for BuzZ topics